Tango Therapeutics TNGX
NASDAQ TNGX
$23.24 -1.21 (-4.95%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Other Non Operating Income (2020 - 2026)

Updated

Tango Therapeutics (TNGX) recorded Other Non Operating Income of $722,000 in Q2 2026, down 20.7% from $910,000 a year earlier and down 33.1% from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Other Non Operating Income (2020 - 2026) Analysis & Trends

On a TTM basis, Tango Therapeutics' Other Non Operating Income came in at $3.89 million as of Jun 30, 2026, down 28.2% year-over-year; for FY2025, it was $4.07 million, down 46.5% from FY2024.

  • Annual Other Non Operating Income has a five-year compound annual growth rate of 102.3% (FY2020 to FY2025).
  • Across earlier years, Other Non Operating Income came in at $7.61 million in FY2024 (+28.0%), $5.94 million in FY2023 (+298.1%), $1.49 million in FY2022 and -$248,000 in FY2021.
  • Quarterly Other Non Operating Income has ranged from -$81,000 in Q4 2021 to $2.18 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Other Non Operating Income rose in two of the last eight quarters, with an average decline of 24.4%.
  • Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 189.5% in Q3 2023, against a decline of 64.0% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.08 million (Q1 2026), $1.38 million (Q4 2025) and $705,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tango Therapeutics 3.91 Bn 2.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 722,000.00
Mar 31, 2026 1.08 Mn
Dec 31, 2025 1.38 Mn
Sep 30, 2025 705,000.00
Jun 30, 2025 910,000.00
Mar 31, 2025 1.07 Mn
Dec 31, 2024 1.48 Mn
Sep 30, 2024 1.96 Mn
Jun 30, 2024 2.00 Mn
Mar 31, 2024 2.18 Mn
Dec 31, 2023 2.06 Mn
Sep 30, 2023 1.51 Mn
Jun 30, 2023 1.15 Mn
Mar 31, 2023 1.22 Mn
Dec 31, 2022 967,000.00
Sep 30, 2022 523,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 -47,000.00
Dec 31, 2021 -81,000.00
Sep 30, 2021 -50,000.00
API Access

Tango Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TNGX&period=max&api_key=YOUR_API_KEY